MR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
27.673
Exchange
XNAS - Nasdaq
3.3
Last period Current ratio
-51%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Moderna
Company Analysis
MRNA valuation, rating, competitors, insights and company profile
Eyestock Rating
MRNA financial analysis by Eyestock methodology
Valuation
MRNA valuation using historical relative method
Statements
MRNA Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRNA dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Moderna`s Current ratio for the last twelve months ended 2024-06-30 is 3.3
